GlaxoSmithKline Consumer Healthcare Limited Financial Results Q3 FY 18-19

Quarter Highlights Revenue increased by 7.5% (HFD Volume Growth 9.6%) Growth is broad based across channels with Base Horlicks volumes growing double digit 37% increase in PBT (Underlying +22%) Continued investment behind brands: 13% of Sales to fund innovation & drive Hlx campaign Drive HFD Consumption Brand building initiatives, continue to strengthen / expand the initiatives: Horlicks continues to drive “Badhne ki Bhook Rag Rag Mein” campaign to bring forth the issue of nutrient absorption. Relaunch of Junior Horlicks with 2-times more DHA content ,one of the key ingredients in driving cognitive development amongst toddlers. This was supported with strong marketing interventions like the New “Tojo” TV campaign. The campaign has been well received and is expected to build equity further in the key markets

Financial Performance: Q3 FY18-19 Net Sales Q3 FY 18-19

Horlicks continues to be at first position in HFD category Market Share Brand Volume Value Horlicks 49.5% Horlicks 43.0% Boost 13.9 % Boost 10.8 % Horlicks continues to be at first position in HFD category Source – AC Nielsen; Market Share MAT Dec 18

Thank You